ARTELO BIOSCIENCES, INC. Gain (Loss) on Extinguishment of Debt
ARTELO BIOSCIENCES, INC. (ARTL) reported Gain (Loss) on Extinguishment of Debt of $42.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was $42.00K.
- ARTELO BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|
| 2026-06-30 | $42.00K 10-Q · filed 2026-08-12 | $42.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | -$825.00K 8-K · filed 2026-03-17 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $0.00 8-K · filed 2026-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |